SCHEMBL6649082

SCHEMBL6649082

CC(C)c1ccncc1-c1nc(-c2ccc(Br)cc2)cs1

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.61
SMN1; SMN2 Q16637 5/20 0.61
RAB9A P51151 5/20 0.61
LMNA P02545 3/20 0.61
CYP19A1 P11511 5/20 0.54
NPC1 O15118 3/20 0.47
SREBF2 Q12772 1/20 0.45
MAPT P10636 4/20 0.44
RECQL P46063 1/20 0.44
ATM Q13315 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44
GAA P10253 1/20 0.44
AR P10275 2/20 0.43
RPS6KA3 P51812 1/20 0.43
ALDH1A1 P00352 2/20 0.43
NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6648507 0.90 KDM4E (0.53) KDM4ESMN1; SMN2RAB9ALMNACYP19A1
SCHEMBL6647162 0.87 KDM4E (0.61) KDM4ESMN1; SMN2RAB9ALMNACYP19A1
SCHEMBL6647407 0.86 KDM4E (0.59) KDM4ESMN1; SMN2RAB9ACYP19A1NPC1
SCHEMBL6647410 0.85 RAB9A (0.49) KDM4ESMN1; SMN2RAB9ALMNACYP19A1
SCHEMBL6628490 0.85 CYP19A1 (0.58) KDM4ESMN1; SMN2RAB9ALMNACYP19A1
SCHEMBL6649092 0.84 GAA (0.50) KDM4ESMN1; SMN2RAB9ALMNACYP19A1
SCHEMBL6646446 0.84 KDM4E (0.55) KDM4ESMN1; SMN2RAB9ALMNACYP19A1
SCHEMBL6649843 0.84 RAB9A (0.60) KDM4ESMN1; SMN2RAB9ALMNACYP19A1
SCHEMBL6648609 0.82 CYP19A1 (0.44) KDM4ESMN1; SMN2RAB9ALMNACYP19A1
SCHEMBL6648219 0.81 CYP19A1 (0.45) KDM4ESMN1; SMN2RAB9ALMNACYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1432706-A2 3-PYRIDYL OR 4-ISOQUINOLINYL THIAZOLES AS C17,20 LYASE INHIBITORS Bayer Pharmaceuticals Corporation (US) 2004-06-30 EP disclosed
WO-2003027085-A2 3-PYRIDYL OR 4-ISOQUINOLINYL THIAZOLES AS C17,20 LYASE INHIBITORS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed